Summary of the values of maximal active force and nH before and after PKA treatment in RP after reconstitution with cTn or PCRF
| Maximal force (mN/mm2) | nH | |
| Fig. 4 B | ||
| Control RP | 179.71 ± 7.04 | 4.47 ± 0.15 |
| cTn | 157.86 ± 4.30a | 3.00 ± 0.12a |
| cTn + PKA | 157.57 ± 4.22a | 3.07 ± 0.15a |
| sTn | 171.86 ± 5.18bc | 4.71 ± 0.36bc |
| Fig. 5 C | ||
| Control RP | 182.14 ± 7.98 | 4.50 ± 0.17 |
| PCRF | 158.14 ± 5.84a | 3.20 ± 0.25a |
| PCRF + PKA | 157.03 ± 5.71a | 3.13 ± 0.23a |
| sTn | 174.43 ± 5.05bc | 4.42 ± 0.16bc |
| Maximal force (mN/mm2) | nH | |
| Fig. 4 B | ||
| Control RP | 179.71 ± 7.04 | 4.47 ± 0.15 |
| cTn | 157.86 ± 4.30a | 3.00 ± 0.12a |
| cTn + PKA | 157.57 ± 4.22a | 3.07 ± 0.15a |
| sTn | 171.86 ± 5.18bc | 4.71 ± 0.36bc |
| Fig. 5 C | ||
| Control RP | 182.14 ± 7.98 | 4.50 ± 0.17 |
| PCRF | 158.14 ± 5.84a | 3.20 ± 0.25a |
| PCRF + PKA | 157.03 ± 5.71a | 3.13 ± 0.23a |
| sTn | 174.43 ± 5.05bc | 4.42 ± 0.16bc |
Maximal force was obtained by activating muscle at pCa 4.5 before plotting of the force-pCa curve at each condition.
P < 0.05 compared with the corresponding values for control RP (before thin filament reconstitution).
P < 0.05 compared with the corresponding values for thin filament reconstitution (before PKA treatment).
P < 0.05 compared with the corresponding values for PKA treatment (before sTn reconstitution).